SGEN – Seattle Genetics Inc
Seattle Genetics, Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seattle Genetics serves customers in the Pacific Northwest.